-
1
-
-
53249090182
-
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
-
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442.
-
(2008)
Eur Heart J
, vol.29
, pp. 2388-2442
-
-
Dickstein, K.1
Cohen-Solal, A.2
Filippatos, G.3
McMurray, J.J.4
Ponikowski, P.5
Poole-Wilson, P.A.6
Stromberg, A.7
Van Veldhuisen, D.J.8
Atar, D.9
Hoes, A.W.10
Keren, A.11
Mebazaa, A.12
Nieminen, M.13
Priori, S.G.14
Swedberg, K.15
Vahanian, A.16
Camm, J.17
De Caterina, R.18
Dean, V.19
Dickstein, K.20
Filippatos, G.21
Funck-Brentano, C.22
Hellemans, I.23
Kristensen, S.D.24
McGregor, K.25
Sechtem, U.26
Silber, S.27
Tendera, M.28
Widimsky, P.29
Zamorano, J.L.30
more..
-
2
-
-
45349090915
-
Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients
-
DOI 10.1093/eurheartj/ehn023
-
Pascual-Figal DA, Domingo M, Casas T, Gich I, Ordonez-Llanos J, Martinez P, Cinca J, Valdes M, Januzzi JL, Bayes-Genis A: Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients. Eur Heart J 2008; 29: 1011-1018. (Pubitemid 351844674)
-
(2008)
European Heart Journal
, vol.29
, Issue.8
, pp. 1011-1018
-
-
Pascual-Figal, D.A.1
Domingo, M.2
Casas, T.3
Gich, I.4
Ordonez-Llanos, J.5
Martinez, P.6
Cinca, J.7
Valdes, M.8
Januzzi, J.L.9
Bayes-Genis, A.10
-
3
-
-
0029880929
-
Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure
-
DOI 10.1016/0735-1097(95)00520-X
-
Pacher R, Stanek B, Hulsmann M, Koller-Strametz J, Berger R, Schuller M, Hartter E, Ogris E, Frey B, Heinz G, Maurer G: Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996; 27: 633-641. (Pubitemid 26081922)
-
(1996)
Journal of the American College of Cardiology
, vol.27
, Issue.3
, pp. 633-641
-
-
Pacher, R.1
Stanek, B.2
Hulsmann, M.3
Koller-Strametz, J.4
Berger, R.5
Schuller, M.6
Hartter, E.7
Ogris, E.8
Frey, B.9
Heinz, G.10
Maurer, G.11
-
4
-
-
25444506344
-
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure
-
DOI 10.1161/CIRCULATIONAHA.104.530972
-
Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P: Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005; 112: 1756-1762. (Pubitemid 41372115)
-
(2005)
Circulation
, vol.112
, Issue.12
, pp. 1756-1762
-
-
Kistorp, C.1
Faber, J.2
Galatius, S.3
Gustafsson, F.4
Frystyk, J.5
Flyvbjerg, A.6
Hildebrandt, P.7
-
5
-
-
79959426382
-
Association between endothelin-1 and adiponectin in chronic heart failure
-
Yin W-H, Chen Y-H, Wei J, Jen H-L, Huang W-P, Young MS, Chen D-C, Liu P-L: Association between endothelin-1 and adiponectin in chronic heart failure. Cardiology 2011;118:207-216.
-
(2011)
Cardiology
, vol.118
, pp. 207-216
-
-
Yin, W-.H.1
Chen, Y-.H.2
Wei, J.3
Jen, H-.L.4
Huang, W-.P.5
Young, M.S.6
Chen, D-.C.7
Liu, P-.L.8
-
6
-
-
0037135523
-
Disruption of adiponectin causes insulin resistance and neointimal formation
-
DOI 10.1074/jbc.C200251200
-
Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T: Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002; 277: 25863-25866. (Pubitemid 34967064)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.29
, pp. 25863-25866
-
-
Kubota, N.1
Terauchi, Y.2
Yamauchi, T.3
Kubota, T.4
Moroi, M.5
Matsui, J.6
Eto, K.7
Yamashita, T.8
Kamon, J.9
Satoh, H.10
Yano, W.11
Froguel, P.12
Nagai, R.13
Kimura, S.14
Kadowaki, T.15
Noda, T.16
-
7
-
-
0038293399
-
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex
-
Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 2003; 46: 459-469. (Pubitemid 36577787)
-
(2003)
Diabetologia
, vol.46
, Issue.4
, pp. 459-469
-
-
Cnop, M.1
Havel, P.J.2
Utzschneider, K.M.3
Carr, D.B.4
Sinha, M.K.5
Boyko, E.J.6
Retzlaff, B.M.7
Knopp, R.H.8
Brunzell, J.D.9
Kahn, S.E.10
-
8
-
-
0034999667
-
Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia
-
DOI 10.1210/jc.86.5.1930
-
Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935. (Pubitemid 32472900)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.5
, pp. 1930-1935
-
-
Weyer, C.1
Funahashi, T.2
Tanaka, S.3
Hotta, K.4
Matsuzawa, Y.5
Pratley, R.E.6
Tataranni, P.A.7
-
9
-
-
10744231067
-
Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian
-
DOI 10.2337/diacare.26.6.1745
-
Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS: Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 2003; 26: 1745-1751. (Pubitemid 36929114)
-
(2003)
Diabetes Care
, vol.26
, Issue.6
, pp. 1745-1751
-
-
Krakoff, J.1
Funahashi, T.2
Stehouwer, C.D.A.3
Schalkwijk, C.G.4
Tanaka, S.5
Matsuzawa, Y.6
Kobes, S.7
Tataranni, P.A.8
Hanson, R.L.9
Knowler, W.C.10
Lindsay, R.S.11
-
10
-
-
0036728279
-
Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes
-
Imagawa A, Funahashi T, Nakamura T, Moriwaki M, Tanaka S, Nishizawa H, Sayama K, Uno S, Iwahashi H, Yamagata K, Miyagawa J, Matsuzawa Y: Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002; 25: 1665-1666.
-
(2002)
Diabetes Care
, vol.25
, pp. 1665-1666
-
-
Imagawa, A.1
Funahashi, T.2
Nakamura, T.3
Moriwaki, M.4
Tanaka, S.5
Nishizawa, H.6
Sayama, K.7
Uno, S.8
Iwahashi, H.9
Yamagata, K.10
Miyagawa, J.11
Matsuzawa, Y.12
-
11
-
-
51649111733
-
Plasma adiponectin for prediction of cardiovascular events and mortality in highrisk patients
-
Maiolino G, Cesari M, Sticchi D, Zanchetta M, Pedon L, Antezza K, Pessina AC, Rossi GP: Plasma adiponectin for prediction of cardiovascular events and mortality in highrisk patients. J Clin Endocrinol Metab 2008; 93: 3333-3340.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 3333-3340
-
-
Maiolino, G.1
Cesari, M.2
Sticchi, D.3
Zanchetta, M.4
Pedon, L.5
Antezza, K.6
Pessina, A.C.7
Rossi, G.P.8
-
12
-
-
51649114505
-
Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis
-
Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M: Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis. Metabolism 2008; 57: 1414-1421.
-
(2008)
Metabolism
, vol.57
, pp. 1414-1421
-
-
Ziegelmeier, M.1
Bachmann, A.2
Seeger, J.3
Lossner, U.4
Kratzsch, J.5
Bluher, M.6
Stumvoll, M.7
Fasshauer, M.8
-
13
-
-
38949090482
-
Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function
-
DOI 10.1530/EJE-07-0454
-
Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H: Circulating high molecular weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function. Eur J Endocrinol 2008;158:197-201. (Pubitemid 351298536)
-
(2008)
European Journal of Endocrinology
, vol.158
, Issue.2
, pp. 197-201
-
-
Fasshauer, M.1
Waldeyer, T.2
Seeger, J.3
Schrey, S.4
Ebert, T.5
Kratzsch, J.6
Lossner, U.7
Bluher, M.8
Stumvoll, M.9
Faber, R.10
Stepan, H.11
-
14
-
-
33744925901
-
Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart
-
DOI 10.1152/ajpheart.00987.2005
-
Fujioka D, Kawabata K, Saito Y, Kobayashi T, Nakamura T, Kodama Y, Takano H, Obata JE, Kitta Y, Umetani K, Kugiyama K: Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am J Physiol Heart Circ Physiol 2006; 290:H2409-H2416. (Pubitemid 43846069)
-
(2006)
American Journal of Physiology - Heart and Circulatory Physiology
, vol.290
, Issue.6
-
-
Fujioka, D.1
Kawabata, K.-I.2
Saito, Y.3
Kobayashi, T.4
Nakamura, T.5
Kodama, Y.6
Takano, H.7
Obata, J.-E.8
Kitta, Y.9
Umetani, K.10
Kugiyama, K.11
-
15
-
-
48449096011
-
MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes
-
Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC: MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes. J Hepatol 2008; 49: 407-416.
-
(2008)
J Hepatol
, vol.49
, pp. 407-416
-
-
Larter, C.Z.1
Yeh, M.M.2
Williams, J.3
Bell-Anderson, K.S.4
Farrell, G.C.5
-
16
-
-
34547586298
-
Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice
-
DOI 10.2337/db07-0127
-
Lin HV, Kim JY, Pocai A, Rossetti L, Shapiro L, Scherer PE, Accili D: Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice. Diabetes 2007; 56: 1969-1976. (Pubitemid 47195822)
-
(2007)
Diabetes
, vol.56
, Issue.8
, pp. 1969-1976
-
-
Lin, H.V.1
Kim, J.-Y.2
Pocai, A.3
Rossetti, L.4
Shapiro, L.5
Scherer, P.E.6
Accili, D.7
-
17
-
-
11144355637
-
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity
-
DOI 10.1074/jbc.M311113200
-
Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE: Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004; 279: 12152-12162. (Pubitemid 38445780)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.13
, pp. 12152-12162
-
-
Pajvani, U.B.1
Hawkins, M.2
Combs, T.P.3
Rajala, M.W.4
Doebber, T.5
Berger, J.P.6
Wagner, J.A.7
Wu, M.8
Knopps, A.9
Xiang, A.H.10
Utzschneider, K.M.11
Kahn, S.E.12
Olefsky, J.M.13
Buchanan, T.A.14
Scherer, P.E.15
|